Resultats de la cerca - Giusy Gentilcore

  • Mostrar 1 - 13 resultats de 13
Refinar resultats
  1. 1
    Revving up Natural Killer Cells and Cytokine-Induced Killer Cells Against Hematological Malignancies

    Revving up Natural Killer Cells and Cytokine-Induced Killer Cells Against Hematological Malignancies per Gianfranco Pittari, Perla Filippini, Giusy Gentilcore, Jean‐Charles Grivel, Sergio Rutella

    Publicat 2015
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  2. 2
    NF-κB as potential target in the treatment of melanoma

    NF-κB as potential target in the treatment of melanoma per Gabriele Madonna, Claudio Dansky Ullman, Giusy Gentilcore, Giuseppe Palmieri, Paolo A. Ascierto

    Publicat 2012
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  3. 3
    Effect of dabrafenib on melanoma cell lines harbouring the BRAF V600D/R mutations

    Effect of dabrafenib on melanoma cell lines harbouring the BRAF V600D/R mutations per Giusy Gentilcore, Gabriele Madonna, Nicola Mozzillo, Antoni Ribas, Antonio Cossu, Giuseppe Palmieri, Paolo A. Ascierto

    Publicat 2013
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  4. 4
    Paracrine Mechanisms of Mesenchymal Stromal Cells in Angiogenesis

    Paracrine Mechanisms of Mesenchymal Stromal Cells in Angiogenesis per Selma Maacha, Heba Sidahmed, Shana Jacob, Giusy Gentilcore, Rita Calzone, Jean‐Charles Grivel, Chiara Cugno

    Publicat 2020
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  5. 5
    Laminins 411 and 421 differentially promote tumor cell migration via α6β1 integrin and MCAM (CD146)

    Laminins 411 and 421 differentially promote tumor cell migration via α6β1 integrin and MCAM (CD146) per Taichi Ishikawa, Zenebech Wondimu, Yuko Oikawa, Giusy Gentilcore, Rolf Kiessling, Søren Brage, Johan Hansson, Manuel E. Patarroyo

    Publicat 2014
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  6. 6
    Distinctive blood and salivary proteomics signatures in Qatari individuals at high risk for cardiovascular disease

    Distinctive blood and salivary proteomics signatures in Qatari individuals at high risk for cardiovascular disease per Ghada Yousif, Selvasankar Murugesan, Mohamed Nadhir Djekidel, Annalisa Terranegra, Giusy Gentilcore, Jean‐Charles Grivel, Souhaila Al Khodor

    Publicat 2025
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  7. 7
    Ipilimumab Treatment Results in an Early Decrease in the Frequency of Circulating Granulocytic Myeloid-Derived Suppressor Cells as well as Their Arginase1 Production

    Ipilimumab Treatment Results in an Early Decrease in the Frequency of Circulating Granulocytic Myeloid-Derived Suppressor Cells as well as Their Arginase1 Production per Yago Pico de Coaña, Isabel Poschke, Giusy Gentilcore, Yumeng Mao, Maria Nyström, Johan Hansson, Giuseppe Masucci, Rolf Kiessling

    Publicat 2013
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  8. 8
    T cells in chronic lymphocytic leukemia display dysregulated expression of immune checkpoints and activation markers

    T cells in chronic lymphocytic leukemia display dysregulated expression of immune checkpoints and activation markers per Marzia Palma, Giusy Gentilcore, Kia Heimersson, Fariba Mozaffari, Barbro Näsman‐Glaser, Emma Young, Richard Rosenquist, Lotta Hansson, Anders Österborg, Håkan Mellstedt

    Publicat 2016
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  9. 9
    Main roads to melanoma

    Main roads to melanoma per Giuseppe Palmieri, Mariaelena Capone, Maria Libera Ascierto, Giusy Gentilcore, David F. Stroncek, Milena Casula, Maria Cristina Sini, Marco Palla, Nicola Mozzillo, Paolo A. Ascierto

    Publicat 2009
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  10. 10
    Antibody‐dependent enhancement (ADE) of SARS‐CoV‐2 in patients exposed to MERS‐CoV and SARS‐CoV‐2 antigens

    Antibody‐dependent enhancement (ADE) of SARS‐CoV‐2 in patients exposed to MERS‐CoV and SARS‐CoV‐2 antigens per Swapna Thomas, Maria K. Smatti, Haya Al‐Sulaiti, Hadeel T. Zedan, Ali H. Eid, Ali Ait Hssain, Laith J. Abu‐Raddad, Giusy Gentilcore, Allal Ouhtit, Asmaa Althani, Gheyath K. Nasrallah, Jean‐Charles Grivel, Hadi M. Yassine

    Publicat 2024
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  11. 11
    Low-dose temozolomide before dendritic-cell vaccination reduces (specifically) CD4+CD25++Foxp3+ regulatory T-cells in advanced melanoma patients

    Low-dose temozolomide before dendritic-cell vaccination reduces (specifically) CD4+CD25++Foxp3+ regulatory T-cells in advanced melanoma patients per Laura Ridolfi, M. Petrini, Anna Maria Granato, Giusy Gentilcore, Ester Simeone, Paolo A. Ascierto, Elena Pancisi, Valentina Ancarani, Laura Fiammenghi, Massimo Guidoboni, Francesco De Rosa, Linda Valmorri, Emanuela Scarpi, Stefania Vittoria Luisa Nicoletti, S Baravelli, Angela Riccobon, Ruggero Ridolfi

    Publicat 2013
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  12. 12
    Assessing a novel immuno-oncology-based combination therapy: Ipilimumab plus electrochemotherapy

    Assessing a novel immuno-oncology-based combination therapy: Ipilimumab plus electrochemotherapy per Nicola Mozzillo, Ester Simeone, Lucia Benedetto, Marcello Curvietto, Diana Giannarelli, Giusy Gentilcore, Rosa Camerlingo, Mariaelena Capone, Gabriele Madonna, Lucia Festino, Corrado Caracò, Gianluca Di Monta, Ugo Marone, Massimiliano Di Marzo, Antonio M. Grimaldi, Stefano Mori, Gennaro Ciliberto, Paolo A. Ascierto

    Publicat 2015
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  13. 13
    Immunological and biological changes during ipilimumab treatment and their potential correlation with clinical response and survival in patients with advanced melanoma

    Immunological and biological changes during ipilimumab treatment and their potential correlation with clinical response and survival in patients with advanced melanoma per Ester Simeone, Giusy Gentilcore, Diana Giannarelli, Antonio M. Grimaldi, Corrado Caracò, Marcello Curvietto, Assunta Esposito, Miriam Paone, Marco Palla, Ernesta Cavalcanti, Fabio Sandomenico, Antonella Petrillo, Gerardo Botti, Franco Fulciniti, Giuseppe Palmieri, Paola Queirolo, Paolo Marchetti, Virginia Ferraresi, Gaetana Rinaldi, Maria Pia Pistillo, Gennaro Ciliberto, Nicola Mozzillo, Paolo A. Ascierto

    Publicat 2014
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:

Eines de cerca: